Dyne Therapeutics, Inc.

Q4 2021 13F Holders

Symbol
DYN
CUSIP
26818M108
Type
Equity
Class
COM
Num filings
95
Total reported value, excl. options
$568 M
Manager Report Date Value ($000) Shares Option Type